Subject Area | Rank | Percentile |
---|---|---|
Category: Medicine Subcategory: Genetics (clinical) |
15 / 99 | |
Category: Medicine Subcategory: Genetics |
63 / 347 | |
Category: Medicine Subcategory: Molecular Biology |
103 / 410 | |
Category: Medicine Subcategory: Molecular Medicine |
47 / 178 |
APC | APC Waiver | Other Charges |
---|---|---|
Yes: Check details ( GBP2390; USD3190; EUR2690; ) | Yes: Check details | No |
Quartiles By JIF | Collection | Quartile | Rank | Percentage |
Category: BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | 50/313 |
|
Category: CELL BIOLOGY | SCIE | Q2 | 52/205 |
|
Category: MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | 30/189 |
|
Quartiles By JCI | Collection | Quartile | Rank | Percentage |
Category: BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | 66/313 |
|
Category: CELL BIOLOGY | SCIE | Q2 | 53/205 |
|
Category: MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | 45/189 |
|
Journal Title | h-index | CiteScore |
---|---|---|
NATURE MEDICINE | 497 | 100.90 |
CELL | 705 | 110.00 |
Molecular Cancer | 103 | 54.90 |
Molecular Plant | 85 | 37.60 |
NUCLEIC ACIDS RESEARCH | 452 | 27.10 |
Molecular Cell | 356 | 26.00 |
PROGRESS IN LIPID RESEARCH | 132 | 24.50 |
TRENDS IN MICROBIOLOGY | 172 | 25.30 |
CELL DEATH AND DIFFERENTIATION | 193 | 24.70 |
Nature Chemical Biology | 182 | 23.90 |
Select your rating and start your review of MOLECULAR MEDICINE
2025-04-01
This is too unfair.........
2025-03-23
The Indian editor avoided the shBh review, and after several major and minor revisions, it took five months before both reviewers accepted and recommended the current version. However, the Indian editor directly rejected the submission, citing ridiculous reasons. He was the one who requested the review in the first place and provided feedback for the revisions. It would have been better not to submit at all. Despite appealing, all communication with the editors was through one email address, and the appeal seemed to have gone nowhere.
2025-02-18
Provide reviewers' opinions after two months, decide whether to directly edit or resend to the reviewers, and use the original reviewers or new ones.
2025-01-16
Too slow.
2025-01-13
The process is going quite smoothly.
2025-01-13
Revision received on December 13, 2024.
Submission accepted on January 8, 2025.
2025-01-08
How is your progress going?
2024-12-15
Those who were deceived into submitting articles by the 1m submission cycle on the website, who would do such a dishonest thing! I waited for 7 months!! But the final result is good, it feels like the Indian editor is too chill and can't find reviewers... Let me summarize the general submission process for reference.
5/24/13 New Submission
5/24/15 Editor Assigned-Reviewers Assigned
5/24/20&22 Under Review
6/5 Editor Assigned
7/15 Send reminder email
7/24/17 Reviewers Assigned
7/24/22 Under Review
7/24/29 Reviewers Assigned
8/1 Under Review
8/15 Reviews Completed
8/16-9/4 a total of 7 times Reviewers Assigned changes
9/9 Major Revision
11/3 Submit for revision
11/6&7 Under Review
12/6 Send reminder email
12/9 Accept
2024-12-04
Submission process (for reference):
Submitted in July, found reviewers in September, revised in October, resubmitted after one month, accepted on December 1st based on the opinion of only one reviewer. The direction is pharmacology with experimental verification, which has many journals for submission and a high acceptance rate.
2024-11-30
How is it going now? Is there any result yet?